Becton, Dickinson and Company (NYSE:BDX) shares hit a new 52-week high during trading on Tuesday following a dividend announcement from the company. The stock traded as high as $226.53 and last traded at $221.50, with a volume of 807900 shares. The stock had previously closed at $220.31.

The newly announced dividend which will be paid on Friday, December 29th. Stockholders of record on Friday, December 8th will be issued a dividend of $0.75 per share. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.34%. The ex-dividend date of this dividend is Thursday, December 7th. This is a boost from Becton, Dickinson and’s previous quarterly dividend of $0.73. Becton, Dickinson and’s payout ratio is 62.80%.

A number of equities research analysts have recently weighed in on the company. Stifel Nicolaus reaffirmed a “buy” rating on shares of Becton, Dickinson and in a report on Wednesday, August 9th. Cowen and Company reiterated a “buy” rating and set a $230.00 price objective on shares of Becton, Dickinson and in a research note on Monday, August 14th. Barclays PLC reiterated an “equal weight” rating and set a $210.00 price objective (up previously from $205.00) on shares of Becton, Dickinson and in a research note on Thursday, August 10th. BidaskClub upgraded shares of Becton, Dickinson and from a “hold” rating to a “buy” rating in a research note on Monday, August 14th. Finally, Zacks Investment Research lowered shares of Becton, Dickinson and from a “buy” rating to a “hold” rating in a research note on Monday, August 7th. Four analysts have rated the stock with a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the stock. The company currently has a consensus rating of “Buy” and an average price target of $217.08.

The company has a market capitalization of $51,030.00, a P/E ratio of 23.34, a PEG ratio of 1.73 and a beta of 1.04. The company has a debt-to-equity ratio of 1.48, a quick ratio of 5.01 and a current ratio of 5.56.

Becton, Dickinson and (NYSE:BDX) last released its quarterly earnings data on Thursday, November 2nd. The medical instruments supplier reported $2.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.37 by $0.03. Becton, Dickinson and had a net margin of 8.52% and a return on equity of 22.51%. The business had revenue of $3.17 billion during the quarter, compared to analyst estimates of $3.14 billion. During the same quarter in the previous year, the business earned $2.12 EPS. Becton, Dickinson and’s quarterly revenue was down 2.0% compared to the same quarter last year. analysts anticipate that Becton, Dickinson and Company will post 10.63 EPS for the current year.

In other Becton, Dickinson and news, insider Stephen Sichak sold 11,787 shares of the business’s stock in a transaction on Friday, September 8th. The shares were sold at an average price of $200.46, for a total transaction of $2,362,822.02. Following the completion of the transaction, the insider now owns 14,038 shares of the company’s stock, valued at approximately $2,814,057.48. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Gary M. Cohen sold 15,512 shares of the business’s stock in a transaction on Monday, September 11th. The stock was sold at an average price of $203.77, for a total transaction of $3,160,880.24. Following the transaction, the insider now directly owns 95,781 shares of the company’s stock, valued at approximately $19,517,294.37. The disclosure for this sale can be found here. 1.40% of the stock is currently owned by insiders.

A number of institutional investors have recently added to or reduced their stakes in the business. Steward Partners Investment Advisory LLC acquired a new position in Becton, Dickinson and during the 3rd quarter worth $1,365,000. Garde Capital Inc. acquired a new position in Becton, Dickinson and during the 3rd quarter worth $1,019,000. Smith Shellnut Wilson LLC ADV lifted its position in Becton, Dickinson and by 16.7% during the 3rd quarter. Smith Shellnut Wilson LLC ADV now owns 2,566 shares of the medical instruments supplier’s stock worth $503,000 after acquiring an additional 368 shares during the last quarter. Hahn Capital Management LLC increased its holdings in shares of Becton, Dickinson and by 1.0% during the 3rd quarter. Hahn Capital Management LLC now owns 217,342 shares of the medical instruments supplier’s stock worth $42,588,000 after purchasing an additional 2,055 shares during the period. Finally, Americafirst Capital Management LLC bought a new position in shares of Becton, Dickinson and during the 3rd quarter worth about $690,000. 87.91% of the stock is owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY NOTICE: This report was originally published by Daily Political and is the sole property of of Daily Political. If you are reading this report on another domain, it was illegally stolen and republished in violation of international copyright & trademark laws. The legal version of this report can be viewed at https://www.dailypolitical.com/2017/11/22/becton-dickinson-and-company-bdx-hits-new-12-month-high-following-dividend-announcement.html.

Becton, Dickinson and Company Profile

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.

Receive News & Ratings for Becton Dickinson and Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Company and related companies with MarketBeat.com's FREE daily email newsletter.